SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Infrastructure Regulatory News (PINT)

Share Price Information for Pantheon Infrastructure (PINT)

Share Price is delayed by 15 minutes
Get Live Data
115.60    -0.60 (-0.52%)
Bid:
115.00
Ask:
116.20
Spread: 1.20 (1.043%)
Market Cap: £541.73m
PINT Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Infrastructure Share Chart

Update research note from QuotedData

7 May 2026 15:14

RNS Number : 4809D
Pantheon Infrastructure PLC
07 May 2026
 

 

Pantheon Infrastructure - Update from QuotedData

7 May 2026

Moving to a new phase

Pantheon Infrastructure (PINT) delivered strong results in 2025, with an NAV total return above its 8-10% target. This was driven by solid operational performance, higher EBITDA and better cash generation. The full-year dividend was increased and fully covered. PINT is now moving from its initial buildout phase to a more mature stage, where cash generation, asset sales and reinvestment are key to returns.

This shift became clearer after year end. The sale of Calpine in January 2026, followed by a partial sale of Intersect, showed PINT's ability to both create and realise value. These deals highlight the strength of its approach: investing in assets with growth potential and recycling capital into new opportunities as the portfolio develops.

Full Research:

https://quoteddata.com/research/pantheon-infrastructure-moving-to-a-new-phase-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Pantheon Infrastructure Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABSGDUDBGDGLR
Date   Source Headline
22nd May 20264:40 pmRNSHolding(s) in Company
8th May 20264:22 pmRNSNotice of AGM
7th May 20263:14 pmRNS-RUpdate research note from QuotedData
31st Mar 20267:00 amRNSAnnual Financial Report
26th Mar 20267:00 amRNSNotice Of Full Year Results
19th Mar 20267:00 amRNSDividend Declaration
6th Mar 202610:30 amRNSHolding(s) in Company
23rd Feb 20267:00 amRNSRevolving Credit Facility
15th Jan 20264:33 pmRNS-RQuotedData's In The HotSeat
23rd Dec 20257:02 amRNSIntersect Power Update
23rd Dec 20257:02 amRNSIntersect Power Update
15th Dec 20257:00 amRNSNet Asset Value
21st Nov 20253:42 pmRNSHolding(s) in Company
10th Oct 202512:31 pmRNSHolding(s) in Company
25th Sep 20257:02 amRNSDividend Declaration
25th Sep 20257:00 amRNSHalf-year Report
23rd Sep 20257:02 amRNSInvestment in US Renewable Energy Company
22nd Sep 20259:00 amRNSNotice Of Half Year Results and Analyst Meeting
29th Jul 20255:07 pmRNS-RUpdate from QuotedData
29th Jul 20253:11 pmRNSHolding(s) in Company
25th Jul 20255:03 pmRNSHolding(s) in Company
24th Jul 20255:03 pmRNSHolding(s) in Company
22nd Jul 202512:18 pmRNSDirector/PDMR Shareholding
9th Jul 202510:50 amRNSDirector/PDMR Shareholding
30th Jun 20257:00 amRNSPublication of Sustainability Report
23rd Jun 20257:00 amRNSNet Asset Value(s)
20th Jun 20253:26 pmRNSResult of AGM and Directorate Changes
17th Jun 202510:40 amRNSDirector Declaration
10th Jun 20257:00 amRNSDirectorate Change
5th Jun 20259:59 amRNSHolding(s) in Company
12th May 20252:40 pmRNSNotice of AGM
7th May 20257:00 amRNSNotice of Capital Markets Event
1st Apr 20257:00 amRNSAnnual Financial Report
27th Mar 20253:10 pmRNSHolding(s) in Company
20th Mar 20253:51 pmRNSDividend Declaration
18th Mar 20257:00 amRNSNotice Of Full Year Results and Analyst Meeting
11th Mar 20252:38 pmRNSHolding(s) in Company
11th Feb 20257:00 amRNSDirectorate Change
14th Jan 20255:45 pmRNSHolding(s) in Company
13th Jan 20257:00 amRNSCalpine Update
30th Dec 20245:02 pmRNSHolding(s) in Company
16th Dec 20247:00 amRNSNet Asset Value(s)
6th Dec 20241:59 pmRNSHolding(s) in Company
1st Nov 20243:26 pmRNSTotal Voting Rights
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.